Marek Fatyga

Enhancing bone healing during distraction osteogenesis with platelet-rich plasma

UNLABELLED Gradual limb lengthening with external fixators using distraction osteogenesis principles is the gold standard for treatment of limb-length discrepancy. However, long treatment time is a major disadvantage of the current lengthening procedures. Efforts to decrease the treatment include biological and biomechanical factors. Injection of platelet-rich plasma (PRP) is a biological method to enhance bone healing during distraction osteogenesis. We hypothesised that PRP can enhance bone healing during limb lengthening. We report our experience with the use of PRP during distraction osteogenesis. This retrospective study included 19 patients divided into the standard group of 10 patients who did not receive PRP and the PRP group of nine patients who received PRP at the end of the distraction phase. The study variables included external fixator time, external fixation index, and complications during treatment. The PRP group had statistically significantly shorter treatment time (p=0.0412). Injection of PRP into regenerate bone might be an effective method to shorten treatment time during limb lengthening and lead to better functional outcomes and improved patient satisfaction. LEVEL OF EVIDENCE Level IV, therapeutic study.

Current insights into the aetiology of adolescent idiopathic scoliosis

Scoliosis occurs in about 0.2–0.6% of the general population. In the majority of cases the cause of this entity remains mostly unidentified. The search for the causes covers almost all aspects of its possible origin. We collected and systematised the contemporary theories and concepts concerning the aetiology of adolescent idiopathic scoliosis. Genetic and hereditary factors are commonly accepted as possible causes; however, the identification of the single gene responsible for the development of this condition seems impossible, which suggests multifactorial mechanism of its formation. Dysfunctions of the nervous system are recognised risks related to the development of scoliosis, but they are classified as belonging to a separate aetiological category. Scoliosis develops at the quickest rate during the child’s growth spurt, which prompted the research on the role of the growth hormone in scoliosis aetiology. Melatonin is another hormone that is studied as a possible factor involved in development of this entity. In cases of progressive scoliosis, increased activity of calmodulin—a protein that regulates the levels of calcium ions—has been observed. The scientists have characterised numerous qualitative and quantitative changes in the composition of the tissue of intervertebral discs, spinal ligaments and paraspinal muscles. Some of the theories, explaining the nature of this entity, presented in this review seem to have only a purely theoretical value; their proliferation only confirms the fact that the actual nature of this condition has not been unveiled yet, and suggests its multifactorial aetiology.

Strategies in early-onset scoliosis treatment

Background: Early-onset spinal deformities are still challenging to pediatric orthopedic surgeons. One still looks for the ideal treatment of these deformities. Preservation of thoracic motion, spine growth, and protection of cardiac and lung function are crucial to the success of the treatment. Purpose: The purpose of this review is to present the readers brief description of available methods of treatment of early- onset scoliosis (EOS). Methods: Authors searched the PubMed for locating and selecting the data. Extracting and synthesizing the data were done by orthopedic surgeons based on their knowledge and experience in the treatment of EOS patients. Results: The current treatment techniques include nonsurgical strategies, such as body cast or brace in younger patients with a smaller curve (